Pharmacy News
Drug safety update: hyoscine butylbromide injection
In Pharmacy News
Stay up to date with all the news, learning and insight in the world of pharmacy.Bookmark
Record learning outcomes
The MHRA has issued the following Drug Safety Update for hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease.
Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease. More information here.
Â